ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GSK Gsk Plc

1,335.50
0.50 (0.04%)
Last Updated: 09:42:28
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 0.04% 1,335.50 1,335.50 1,336.00 1,337.50 1,333.00 1,335.00 443,768 09:42:28
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1889 11.24 55.34B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,335p. Over the last year, Gsk shares have traded in a share price range of 1,282.50p to 1,820.00p.

Gsk currently has 4,145,087,815 shares in issue. The market capitalisation of Gsk is £55.34 billion. Gsk has a price to earnings ratio (PE ratio) of 11.24.

Gsk Share Discussion Threads

Showing 26901 to 26923 of 34075 messages
Chat Pages: Latest  1087  1086  1085  1084  1083  1082  1081  1080  1079  1078  1077  1076  Older
DateSubjectAuthorDiscuss
06/6/2021
11:26
Best qualified??????

Do me a favour. Even she admitted recently that she was surprised by the appointment.

spud

spud
06/6/2021
11:17
Actually I was quite encouraged. Maybe the Tesaro acquisition not too bad after all if it looks as though Zejula might have greater sales potential on multiple indications

Expecting the share price to grind higher over time

daneswooddynamo
06/6/2021
11:14
Improving financials will help sentiment.
alex1621
06/6/2021
10:42
No really bothered about CEO etc etc
I just want to know is will all this current carry on in the media and else where make the price
rise next week?

Anyone with any ideas?
On face value, I tend to think we might get a bit of a rise as all
publicity is still publicity.

netcurtains
06/6/2021
10:25
She got the job because she is surrounded by hen-pecked directors,all of them getting she-male drugs maybe made by GSK .
abdullla
06/6/2021
09:43
She got the job because
1) Diversity.

geckotheglorious
06/6/2021
09:35
Yes but it's like shooting at am open goal. The rewards are huge but the buck stops at the top. She did not get the job because she was the best qualified person for the role.
meijiman
06/6/2021
09:35
Elliot had a stake in Sky in 2018, so you can be sure that him and Murdoch are on talking terms.
alex1621
06/6/2021
08:10
Front page The SundayTimes
Astra and Glaxo in cancer battle

AZ taking Glaxo to court for more share of royalty payments .

Also making comparison 18% fall in Glaxo share price since Emma and 64% rise in Astra over same period .

It's an attack on Emma . This paper is becoming mouth piece for Elliot?

whatsup32
05/6/2021
19:58
Expiration date of offer was 23 June. I'm sure that's not a coincidence.
alex1621
05/6/2021
19:21
The fun starts here.

No idea what they're up to, not sure I've seen an offer like that before.

I think I'll put in an offer in to trc of £5 for 0.1% of the gsk share they own. Nothing to lose.

pierre oreilly
05/6/2021
18:31
Testing the water and to see what support the larger funds give to the proposal. Or support they don't give to GSK and the CEO, so forcing the issue and possibly the share price with it.
finctastic
05/6/2021
09:43
Just commencement of negotiations imo. spud
spud
05/6/2021
08:55
Mini tender offers are a ruse to trick holders out of their shares, an attempt to catch the unwary off guard. I'm amazed they are even allowed.
alex1621
05/6/2021
08:51
Spud.
Got be be crackers to accept a tender offer BELOW the current market price!!!

:)

geckotheglorious
05/6/2021
08:16
GSK encourages ADS holders to reject TRC Capital "mini-tender" offer (Alliance News) - GlaxoSmithKline PLC on Friday noted a "mini-tender" offer by TRC Capital ...

Alliance News4 June, 2021

(Alliance News) - GlaxoSmithKline PLC on Friday noted a "mini-tender" offer by TRC Capital Investment Corp and recommended its shareholders reject it.

Investment firm TRC Capital intends to purchase up to 3.0 million American depositary shares at a price of USD37.10 each in cash.

As described by TRC Capital, its offer is being made at a 4.5% discount to the closing price of USD38.85 per share on May 21, the last trading day before the offer commenced.

The pharmaceutical company said it "does not endorse" TRC Capital's offer and recommends that ADS holders reject the offer.

GlaxoSmithKline shares were trading 0.7% higher in London on Friday at 1,353.20 pence each. Its ADS were up 0.5% in New York at USD38.91 each.

spud

spud
05/6/2021
07:14
Interest is payable daily on borrowed money,no time to wait for next day,do not leave it till tomorrow what you can do today."
abdullla
05/6/2021
07:07
Why would they not sell on open market on Monday morning?
watfordhornet
05/6/2021
06:34
Investors who bought GSK shares with borrowed money might take up this low offer and sell their holdings to get out of this uncertainty.
abdullla
04/6/2021
20:51
Made offer 5% below closing price , stated they have done thus many times before with other companies.

Not sure why they would think shareholders would accept it given. They can get 5% more at current prices.

whatsup32
04/6/2021
20:01
What this mini tender offer at 4pm today announcement. Has Elliot management made a offer
notbitcoin
03/6/2021
14:52
GSK now vertical rise may be Pfizer helped.
abdullla
03/6/2021
14:40
Not to me I don't drink.
abdullla
Chat Pages: Latest  1087  1086  1085  1084  1083  1082  1081  1080  1079  1078  1077  1076  Older